Article

Donation funds eye care in underserved communities

Optos participated in the World Sight Day Company Challenge by making a donation to Optometry Giving Sight for each retinal screening image made using its tool (Optomap) on World Sight Day, Oct. 13.

Dunfermline, Scotland-Optos participated in the World Sight Day Company Challenge by making a donation to Optometry Giving Sight for each retinal screening image made using its tool (Optomap) on World Sight Day, Oct. 13.

“We are pleased to make this donation to help underserved communities worldwide access sustainable eye care,” said Roy Davis, chief executive officer of Optos, which has worldwide headquarters in Dunfermline, Scotland, and North American headquarters in Malborough, MA.

Optometry Giving Sight, based in Sydney, Australia, with U.S. offices in Golden, CO, is a joint initiative of the World Optometry Foundation, the International Centre for Eyecare Education, and the International Agency for the Prevention of Blindness. Eighty-five percent of donations to the nonprofit initiative directly support projects that provide vision care, local training, and infrastructure support to people in underserved communities, according to the organization.

“With the help of Optos and other companies and practitioners who have signed up for the World Sight Day Challenge, Optometry Giving Sight is funding sustainable vision-care programs worldwide and bringing the gift of vision to those most in need,” said Mary Anne Murphy, OD, chairwoman of Optometry Giving Sight.

Industry sponsors of Optometry Giving Sight include the Brien Holden Vision Institute, CIBA Vision Corp., CooperVision, Marchon Eyewear Inc., Vision Source!, ABB Concise, AllAboutVision, Wolters Kluwer Pharma Solutions VisionCare Group, Transitions Optical, First Vision Media Group Inc., and the International Vision Expo & Conference.

World Sight Day is an initiative of Vision 2020: The Right to Sight. It is supported by the World Health Organization, the International Agency for the Prevention of Blindness, and non-government organizations with the shared goal of eliminating avoidable blindness by 2020.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.